IMPAACT and VESTED assessed pregnancy outcomes and viral suppression status for pregnant women with HIV undergoing treatment with antiretroviral agents.
By exploring links between fasting plasma citrate and succinate levels, researchers tested their hypothesis that a metabolic shift may contribute to neurocognitive impairment in people with HIV.
Life expectancy among people with HIV receiving antiretroviral therapy (ART) has significantly improved in Latin America and the Caribbean.
People living with HIV without known cardiovascular disease have an increased prevalence and volume of noncalcified coronary plaque.
One aim of this study was to compare breast cancer survivors and HIV patients, both with neuropathic pain, with regard to psychological factors and health-related quality of life.
One in four people with HIV experience intimate partner violence, according to recently published study.
For people with HIV receiving tenofovir-based ART, replacing TDF with TAF is associated with adverse metabolic changes.
For veterans with HIV and hypertension, the rate of CVD events is high and is increased in association with ß-blocker use.
Study authors evaluated the association between HIV diagnosis and COVID-19 diagnosis, hospitalization, and in-hospital death in New York State.
For people with HIV, deferral of antiretroviral therapy has a small effect on increasing the 10-year risk for cancer.
